<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>FDA approves a new blood test to detect signs of Alzheimer’s — Live Feed</title><link>https://www.live-feeds.com/feed/fda-approves-a-new-blood-test-to-detect-signs-of-alzheimer-s</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/fda-approves-a-new-blood-test-to-detect-signs-of-alzheimer-s/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>FDA Approves Blood Test to Detect Alzheimer's Signs</title><link>https://www.live-feeds.com/feed/fda-approves-a-new-blood-test-to-detect-signs-of-alzheimer-s</link><guid isPermaLink="false">https://www.live-feeds.com/feed/fda-approves-a-new-blood-test-to-detect-signs-of-alzheimer-s#u49356</guid><pubDate>Thu, 27 Aug 2026 00:48:03 +0000</pubDate><description>The US FDA has approved a blood test developed by Roche and Eli Lilly to detect signs of Alzheimer&amp;#039;s disease. The test, called Elecsys pTau-217, will be available through Labcorp and can be used in both primary and specialty care settings. This approval provides a new tool for diagnosing Alzheimer&amp;#039;s, a disease that affects millions of people worldwide.Why it mattersAlzheimer&amp;#039;s disease is a progressive neurological disorder that can cause memory loss, cognitive decline, and eventually death. Early detection and diagnosis are crucial for managing the disease and developing effecti</description></item>
</channel></rss>